国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
21期
2885-2886
,共2页
高血压%胱抑素C%N端脑钠肽前体
高血壓%胱抑素C%N耑腦鈉肽前體
고혈압%광억소C%N단뇌납태전체
hypertension%cystatin C%N-terminal pro-brain natriuretic peptid
目的:探讨高血压患者血清胱抑素C(CysC)和N端脑钠肽前体(NT-proBNP)水平的变化。方法选取89例高血压患者并分为5个亚组:A组(20例),单纯性高血压组;B组(18例),高血压合并左心肥厚组;C组(15例),高血压合并心力衰竭组;D组(17例),高血压合并早期肾功能损害组;E组(19例),高血压合并冠心病组。并选取20例健康体检者作为对照组,测定各组血清CysC和NT-proBNP水平。结果 B、C、D组的CysC水平高于对照组,E组CysC水平低于对照组,差异均有统计学意义(P<0.05)。D组的NT-proBNP水平高于对照组(P<0.05),B、C、E组NT-proBNP水平显著高于对照组(P<0.01),差异均有统计学意义。结论测定高血压患者血清CysC和NT-proBNP水平可以了解病情的发展及合并疾病发生情况,为临床治疗提供依据。
目的:探討高血壓患者血清胱抑素C(CysC)和N耑腦鈉肽前體(NT-proBNP)水平的變化。方法選取89例高血壓患者併分為5箇亞組:A組(20例),單純性高血壓組;B組(18例),高血壓閤併左心肥厚組;C組(15例),高血壓閤併心力衰竭組;D組(17例),高血壓閤併早期腎功能損害組;E組(19例),高血壓閤併冠心病組。併選取20例健康體檢者作為對照組,測定各組血清CysC和NT-proBNP水平。結果 B、C、D組的CysC水平高于對照組,E組CysC水平低于對照組,差異均有統計學意義(P<0.05)。D組的NT-proBNP水平高于對照組(P<0.05),B、C、E組NT-proBNP水平顯著高于對照組(P<0.01),差異均有統計學意義。結論測定高血壓患者血清CysC和NT-proBNP水平可以瞭解病情的髮展及閤併疾病髮生情況,為臨床治療提供依據。
목적:탐토고혈압환자혈청광억소C(CysC)화N단뇌납태전체(NT-proBNP)수평적변화。방법선취89례고혈압환자병분위5개아조:A조(20례),단순성고혈압조;B조(18례),고혈압합병좌심비후조;C조(15례),고혈압합병심력쇠갈조;D조(17례),고혈압합병조기신공능손해조;E조(19례),고혈압합병관심병조。병선취20례건강체검자작위대조조,측정각조혈청CysC화NT-proBNP수평。결과 B、C、D조적CysC수평고우대조조,E조CysC수평저우대조조,차이균유통계학의의(P<0.05)。D조적NT-proBNP수평고우대조조(P<0.05),B、C、E조NT-proBNP수평현저고우대조조(P<0.01),차이균유통계학의의。결론측정고혈압환자혈청CysC화NT-proBNP수평가이료해병정적발전급합병질병발생정황,위림상치료제공의거。
Objective To investigate the changes of serum levels of CysC and NT-proBNP in patients with hypertension .Meth-ods 89 patients with hypertension were selected and divided into five subgroups:Group A (n= 20) with simple hypertension;Group B(n=18) with hypertension and left ventricular hypertrophy ;Group C(n=15) with hypertension and heart failure;Group D(n=17) with hypertension and early renal damage;Group D(n=19) with hypertension and coronary heart disease .20 healthy in-dividuals were selected as control group .The serum levels of CysC and NT-proBNP were measured in all the groups .Results The serum levels of CysC in group B ,C and D were higher than control group (P<0 .05) ,and serum CysC level in group E was lower than control group(P<0 .05) .The serum level of NT-proBNP in group D was higher than control group(P<0 .05) ,and the serum NT-proBNP levels in group B ,C and E were significantly higher than control group (P<0 .01) .Conclusion The detection of CysC and NT-proBNP in patients with hypertension is helpful for understanding the progression of the disease and the occurrence of amalgamative diseases ,and it provides positive proof for clinical treatment .